Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 3, Pages 638-646
Publisher
Oxford University Press (OUP)
Online
2012-11-22
DOI
10.1093/carcin/bgs367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: A novel cyclooxygenase-inhibition-independent effect
- (2011) Tomoko Kato et al. BIOCHEMICAL PHARMACOLOGY
- Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3
- (2011) S. Chen et al. CANCER RESEARCH
- The Number of Lymph Node Metastases as a Prognostic Factor in Patients With N1 Non-small Cell Lung Cancer
- (2011) Sirisha Jonnalagadda et al. CHEST
- Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
- (2011) Olorunseun O. Ogunwobi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
- (2011) Andrea Koch et al. EUROPEAN JOURNAL OF CANCER
- The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma
- (2011) Jing Ai et al. JNCI-Journal of the National Cancer Institute
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines
- (2010) Seok-Woo Park et al. ANTI-CANCER DRUGS
- Activated PI3K/Akt/COX-2 Pathway Induces Resistance to Radiation in Human Cervical Cancer HeLa Cells
- (2010) Shu Xia et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Lung cancer progression and metastasis from the prognostic point of view
- (2010) Kentaro Inamura et al. CLINICAL & EXPERIMENTAL METASTASIS
- KRASmutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach
- (2010) Young-Kwang Yoon et al. MOLECULAR CARCINOGENESIS
- Celecoxib Antagonizes the Cytotoxicity of Cisplatin in Human Esophageal Squamous Cell Carcinoma Cells by Reducing Intracellular Cisplatin Accumulation
- (2010) L. Yu et al. MOLECULAR PHARMACOLOGY
- Management and Prognosis in Synchronous Solitary Resected Brain Metastasis from Non–Small-Cell Lung Cancer
- (2009) Alexander V. Louie et al. Clinical Lung Cancer
- Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells
- (2009) Y.-K. Yoon et al. MOLECULAR CANCER THERAPEUTICS
- Cyclooxygenase-2 Expression Is Related to the Epithelial-to-Mesenchymal Transition in Human Colon Cancers
- (2009) Tae Jung Jang et al. YONSEI MEDICAL JOURNAL
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression
- (2008) X. Zhao et al. CANCER RESEARCH
- Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF- through a PGE2-dependent mechanisms
- (2008) J. R. Neil et al. CARCINOGENESIS
- The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non-Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib
- (2008) M. J. Fidler et al. CLINICAL CANCER RESEARCH
- Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203
- (2008) Martin J. Edelman et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib Plus Celecoxib in Chemotherapy-Naïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: A Phase II Study from the Hoosier Oncology Group
- (2008) Anuj Agarwala et al. Journal of Thoracic Oncology
- Transforming growth factor-β1 increases cell migration and β1 integrin up-regulation in human lung cancer cells
- (2008) Yi-Chin Fong et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now